The World Is Running Out of Much Needed New Antibiotics
Posters: Misuse of antibiotics and risks. Credit: WHOBy Baher KamalROME, Oct 4 2017 (IPS)The world is running out of new antibiotics to combat the growing threat of antimicrobial resistance, a new specialised report warns ahead of this year’s World Antibiotic Awareness Week, adding that most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. The latest World Health Organization (WHO) report on this issue “Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis” found very few potential treatment options for those antibiotic-resistant infections identified by the organisation as posing the “greatest threat to health,” including drug-resistant tuberculosis which kills around 250,000 people each year.Fact sheet on antibiotic resistance • Antibiotic resistance is one of the biggest threats to global health, food security, and development today. • Antibiotic resistance can affect anyone, of any age, in any country. • Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. • A growing number of infections – such as pneumonia, tuberculosis, and gonorrhoea – are becoming harder to treat as the antibiotics used to treat them become less effective. • Antibiotic resistance leads to longer hospit...
Most women who are notified by mail that they have a high risk of breast cancer are unlikely to do anything about it, a small study suggests.Reuters Health Information
ConclusionsOur study reveals the need for targeted patient ‐education about the benefits and limitations of follow‐up. In order to meet increasing costs of cancer care, individualized follow‐up procedures adjusted to risk of recurrence and late‐effects in cervical cancer survivors are warranted.
Radiation therapy vendor Varian Medical Systems has added new artificial intelligence...Read more on AuntMinnie.comRelated Reading: Varian gets FDA nod for Ethos adaptive therapy unit Varian posts strong Q1 sales growth as profit slips Varian installs systems in Africa, U.S. Varian awarded Mich. cancer software contract Varian posts continued revenue gains in Q4, fiscal 2019
The Department of Health and Human Services outlined support for Moderna and Johnson &Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.(Image credit: David L. Ryan/Boston Globe via Getty Images)
AbstractNeuropathic pain (NeP) is an intractable pain caused by a lesion or disease of the somatosensory nervous system. NeP is often challenging to manage because most of the mechanisms remain to be elucidated. Recent investigations in the field of autoimmune neurology have demonstrated that specific autoantibodies against antigens in the somatosensory pathway can cause NeP. Detection of pathogenic autoantibodies in NeP adds to the understanding of the mechanism of pain, which might aid in the development of novel immunotherapies. Therefore, it is necessary to explore novel NeP ‐related autoantibodies to improve the man...
The number of deaths from coronavirus in the United Kingdom rose by 27% in the space of a day, according to new figures on Tuesday that a senior cabinet minister described as shocking and disturbing.
The first medical ventilators which Britain has recently ordered from businesses will be ready this weekend and available to the National Health Service next week, as the country seeks to boost capacity in the coronavirus outbreak.
There are signs that social distancing measures are starting to slow the spread of coronavirus in Britain but that does not mean that the new rules should be relaxed, Cabinet Office Minister Michael Gove said on Tuesday.
Israel has begun testing a COVID-19 vaccine prototype on rodents at its bio-chemical defense laboratory, a source said on Tuesday.
Publication date: Available online 30 March 2020Source: The Lancet HIVAuthor(s): Harriet Mayanja-Kizza
More News: African Health | Antimicrobial Resistance | Cancer | Cancer & Oncology | Cancer Vaccines | Clostridium Difficile | Emergency Medicine | Germany Health | Gonorrhoea | Hospitals | Infectious Diseases | International Medicine & Public Health | Luxembourg Health | Multidrug Resistance | Netherlands Health | Parasitic Diseases | Parasitology | Partnerships | Pneomococcal Vaccine | Pneumonia | Poisoning | South Africa Health | Superbugs | Switzerland Health | Tuberculosis | UK Health | United Nations | Urinary Tract Infections | Vaccines | Veterinary Vaccinations | WHO